Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda

Abstract	Tobacco dependence pharmacotherapy (TDP) plays a major role in smoking cessation. We conducted a rapid assessment of current smoking, availability of TDP and the willingness to quit and to pay for TDP among 56 patients with tobacco-attributable diseases and 38 pharmacies in Uganda. Of the 56 patients, 63% were current smokers, 77.4% wanted to quit and 37% were willing to pay. Drugs were largely unavailable: nicotine replacement products were available in only seven pharmacies (18%) and bupropion in three (8%); these cost respectively US$15.7 and US$17.1 for a 1-month supply. Improving supplies and lowering prices could facilitate access to TDP in Uganda. Keywords: Uganda; pharmacotherapy; tobacco dependence.
Date of Publication	21 March 2016
URL	https://pubmed.ncbi.nlm.nih.gov/27051610
PMID	27051610
PMCID	PMC4809727
DOI	10.5588/pha.15.0070